• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.多次服用奥美拉唑对单次口服地高辛药代动力学的轻微影响。
Br J Clin Pharmacol. 1991 Nov;32(5):569-72. doi: 10.1111/j.1365-2125.1991.tb03953.x.
2
Drug-drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects.健康受试者中氢氧化氧铁蔗糖与氯沙坦、呋塞米、奥美拉唑、地高辛和华法林之间的药物相互作用。
J Nephrol. 2014 Dec;27(6):659-66. doi: 10.1007/s40620-014-0080-1. Epub 2014 Apr 4.
3
Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers.罗非昔布对健康志愿者地高辛药代动力学的影响。
J Clin Pharmacol. 2001 Jan;41(1):107-12. doi: 10.1177/00912700122009755.
4
Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.泮托拉唑与地高辛在人体治疗剂量下无相互作用。
Int J Clin Pharmacol Ther. 1995 Sep;33(9):481-5.
5
The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteers.替米沙坦对健康男性志愿者体内地高辛稳态药代动力学的影响。
J Clin Pharmacol. 2000 Dec;40(12 Pt 1):1373-9.
6
Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.泮托拉唑与地高辛在人体治疗剂量下无相互作用。
Int J Clin Pharmacol Ther. 1996 May;34(1 Suppl):S67-71.
7
The influence of gastric pH on the pharmacokinetics of fluconazole: the effect of omeprazole.胃内pH值对氟康唑药代动力学的影响:奥美拉唑的作用
Int J Clin Pharmacol Ther. 1994 Sep;32(9):491-6.
8
Lack of effect of eprosartan on the single dose pharmacokinetics of orally administered digoxin in healthy male volunteers.依普罗沙坦对健康男性志愿者口服地高辛单剂量药代动力学无影响。
Br J Clin Pharmacol. 1997 Jun;43(6):661-4. doi: 10.1046/j.1365-2125.1997.00608.x.
9
Pharmacokinetic and pharmacodynamic drug interactions between digoxin and macrogol 4000, a laxative polymer, in healthy volunteers.地高辛与泻药聚乙二醇4000在健康志愿者体内的药代动力学和药效学药物相互作用。
Br J Clin Pharmacol. 1999 Sep;48(3):453-6. doi: 10.1046/j.1365-2125.1999.00025.x.
10
A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide.一项随机研究调查奥美拉唑对口服司美格鲁肽药代动力学的影响。
Expert Opin Drug Metab Toxicol. 2018 Aug;14(8):869-877. doi: 10.1080/17425255.2018.1488965. Epub 2018 Jun 30.

引用本文的文献

1
Assessment of potential drug-drug interactions among outpatients in a tertiary care hospital: focusing on the role of P-glycoprotein and CYP3A4 (retrospective observational study).三级护理医院门诊患者潜在药物相互作用的评估:聚焦于P-糖蛋白和CYP3A4的作用(回顾性观察研究)
Heliyon. 2022 Oct 28;8(11):e11278. doi: 10.1016/j.heliyon.2022.e11278. eCollection 2022 Nov.
2
Evaluation of the drug-drug interaction potential of treosulfan using a physiologically-based pharmacokinetic modelling approach.采用基于生理的药代动力学建模方法评估替莫唑胺的药物相互作用潜力。
Br J Clin Pharmacol. 2022 Feb;88(4):1722-1734. doi: 10.1111/bcp.15081. Epub 2021 Oct 13.
3
Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.老年人使用质子泵抑制剂:权衡风险与获益——一个由来已久的问题
Curr Gastroenterol Rep. 2019 Dec 5;21(12):65. doi: 10.1007/s11894-019-0732-3.
4
Physiologically-Based Pharmacokinetic Modeling Approach to Predict Rifampin-Mediated Intestinal P-Glycoprotein Induction.基于生理学的药代动力学模型预测利福平介导的肠道 P 糖蛋白诱导作用。
CPT Pharmacometrics Syst Pharmacol. 2019 Sep;8(9):634-642. doi: 10.1002/psp4.12458. Epub 2019 Sep 5.
5
The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events.质子泵抑制剂相关不良反应的临床指南。
Drugs. 2019 May;79(7):715-731. doi: 10.1007/s40265-019-01110-3.
6
Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy Volunteers.奥美拉唑对健康志愿者体内伊曲康唑药代动力学影响的机制评估
Eur J Drug Metab Pharmacokinet. 2019 Apr;44(2):201-215. doi: 10.1007/s13318-018-0519-1.
7
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens.克拉霉素、咪达唑仑和地高辛:应用生理药代动力学(PBPK)模型深入了解药物相互作用和联合用药方案。
AAPS J. 2017 Jan;19(1):298-312. doi: 10.1208/s12248-016-0009-9. Epub 2016 Nov 7.
8
Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers.健康志愿者单次口服给药后CIME联合用药及其代谢产物的安全性和药代动力学。
Eur J Drug Metab Pharmacokinet. 2016 Apr;41(2):125-38. doi: 10.1007/s13318-014-0239-0. Epub 2014 Dec 3.
9
Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactions.非洛地平作为药代动力学药物相互作用潜在引发剂的评估。
Eur J Clin Pharmacol. 2014 Sep;70(9):1115-22. doi: 10.1007/s00228-014-1716-8. Epub 2014 Jul 17.
10
Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update.质子泵抑制剂的药代动力学药物相互作用概况:最新进展。
Drug Saf. 2014 Apr;37(4):201-11. doi: 10.1007/s40264-014-0144-0.

本文引用的文献

1
Influence of gastric pH on digoxin biotransformation. II. Extractable urinary metabolites.胃内pH值对地高辛生物转化的影响。II. 可提取的尿代谢物。
Clin Pharmacol Ther. 1981 Feb;29(2):181-90. doi: 10.1038/clpt.1981.29.
2
Single- and multiple-dose kinetics of intravenous digoxin.
Clin Pharmacol Ther. 1980 Sep;28(3):340-5. doi: 10.1038/clpt.1980.171.
3
Influence of gastric pH on digoxin biotransformation. I. Intragastric hydrolysis.胃内pH值对地高辛生物转化的影响。I. 胃内水解作用。
Clin Pharmacol Ther. 1980 Jan;27(1):16-21. doi: 10.1038/clpt.1980.3.
4
Structure-activity correlation of the lethality and central effects of selected cardiac glycosides.所选强心苷的致死性与中枢作用的构效关系
J Pharmacol Exp Ther. 1966 Jun;152(3):501-8.
5
Pharmacokinetics and metabolism of digoxigenin-mono-digitoxoside in man.洋地黄毒苷元-单洋地黄毒糖苷在人体内的药代动力学与代谢
Eur J Clin Pharmacol. 1974;7(2):87-94. doi: 10.1007/BF00561320.
6
Comparison of digoxin with some digitoxin metabolites on cat heart lung preparation.
Eur J Pharmacol. 1973 Apr;22(1):109-11. doi: 10.1016/0014-2999(73)90192-1.
7
Pharmacokinetic interactions of cimetidine 1987.西咪替丁的药代动力学相互作用,1987年。
Clin Pharmacokinet. 1987 May;12(5):321-66. doi: 10.2165/00003088-198712050-00002.
8
Dose-independent pharmacokinetics of digoxin in humans.
Am Heart J. 1978 Oct;96(4):507-11. doi: 10.1016/0002-8703(78)90162-x.

多次服用奥美拉唑对单次口服地高辛药代动力学的轻微影响。

Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose.

作者信息

Oosterhuis B, Jonkman J H, Andersson T, Zuiderwijk P B, Jedema J N

机构信息

Pharma Bio-Research International B.V., Zuidlaren, The Netherlands.

出版信息

Br J Clin Pharmacol. 1991 Nov;32(5):569-72. doi: 10.1111/j.1365-2125.1991.tb03953.x.

DOI:10.1111/j.1365-2125.1991.tb03953.x
PMID:1954072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1368632/
Abstract
  1. The influence of multiple dose administration of omeprazole on the pharmacokinetics of oral digoxin was studied in 10 healthy male volunteers. 2. In a randomized two-way crossover design a single dose of 1 mg digoxin was administered either alone (control) or on day 8 of an 11 day course of omeprazole 20 mg once daily. 3. Plasma digoxin concentrations were measured over 96 h after digoxin administration with a [125I]-r.i.a. method. 4. On average, Cmax and AUC values for digoxin were approximately 10% higher and tmax tended to be shorter during the administration of omeprazole, while the elimination rate constant was unaffected. 5. The increase in AUC(0,96 h) was statistically significant (P less than 0.05), but within the accepted range for bioequivalence. In two subjects the increase was approximately 30%. 6. It is concluded that co-treatment with omeprazole causes a minor increase in the absorption of oral digoxin. The magnitude of this effect is not considered to be clinically relevant for the majority of patients.
摘要
  1. 在10名健康男性志愿者中研究了多次服用奥美拉唑对口服地高辛药代动力学的影响。2. 采用随机双向交叉设计,单次给予1 mg地高辛,给药方式分为单独给药(对照)或在每日一次服用20 mg奥美拉唑的11日疗程的第8天给药。3. 用地高辛给药后96小时内,采用[125I]-放射免疫分析法测定血浆地高辛浓度。4. 平均而言,服用奥美拉唑期间,地高辛的Cmax和AUC值约高10%,tmax趋于缩短,而消除速率常数未受影响。5. AUC(0,96 h)的增加具有统计学意义(P<0.05),但在生物等效性的可接受范围内。在两名受试者中,增加约30%。6. 得出的结论是,与奥美拉唑联合治疗会使口服地高辛的吸收略有增加。对于大多数患者而言,这种效应的程度不被认为具有临床相关性。